Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy Adults

NCT04175808 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

QT Intervals Changes
QTc Intervals Changes

Interventions

DRUG: Omecamtiv Mecarbil (OM)
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Cytokinetics